[1] XU J, KOIZUMI K, LIU M, et al.Shikonin induces an anti-tumor effect on murine mammary cancer via p38-dependent apoptosis[J]. Oncol Rep, 2019, 41(3): 2020-2026. [2] SHEN LM, JIANG SM, YAO Y, et al.Analysis of one case of liver injury caused by chemotherapy in breast cancer[J]. Chinese Journal of Pharmacovigilance(中国药物警戒), 2020,17(10): 703-706. [3] JIA Y, LIN R, JIN H, et al.MicroRNA-34 suppresses proliferation of human ovarian cancer cells by triggering autophagy and apoptosis and inhibits cell invasion by targeting Notch 1[J]. Biochimie, 2019, 160(35): 193-199. [4] ARGEL AV, NABILA H, DANILO DG, et al.Translational control of depression-like behavior via phosphorylation of eukaryotic translation initiation factor 4E[J]. Nature Communications, 2018, 9(1): 2459-2460. [5] SINGH P, CHEN H, CHI Y, et al.Structural basis of human translation initiation factor eIF4G-enhanced helicase activity of eIF4A in tumorigenesis[J]. Cancer Research, 2018, 78(13): 4447-4447. [6] PETTERSSON F, RINCON S, EMOND A, et al.Genetic and pharmacologic inhibition of eIF4E reduces breast cancer cell migration, invasion, and metastasis[J]. Cancer Res, 2015, 75(6): 1102-1112. [7] HEIKKINEN T, KHAN S, HUOVARI E, et al.Evaluation of the RHINO gene for breast cancer predisposition in finnish breast cancer families[J]. Breast Cancer Research & Treatment, 2014, 144(2): 437-439. [8] MARTÍNEZ-MONTEMAYOR MM, ACEVEDO RR, OTERO-FRANQUI E, et al. Ganoderma lucidum (Reishi) inhibits cancer cell growth and expression of key molecules in inflammatory breast cancer[J]. Nutrition and Cancer, 2011, 63(7): 1085-1094. [9] GRÜNER S, RAMONA W, DANIEL P, et al. Structural motifs in eIF4G and 4E-BPs modulate their binding to eIF4E to regulate translation initiation in yeast[J]. Nucleic Acids Res, 2018, 46(13): 6893-6908. [10] PAN X.Targeting of elF4G miR-503 enhance drug sensitivity ofMCF-7/ADR cells[D]. Hengyang: University of South China(南华大学), 2016. [11] SUN YY, CAO YD, YE WX, et al.The effects of EIF4E gene down-regulation induced by siRNA on the proliferation and cell cycle of human breast cancer cell line MDA-MB-231[J]. Tumor(肿瘤), 2011, 31(3): 197-202. [12] LI P, REN B, LI HL, et al.Inhibition of epithelial-mesenchymal transition of MDA-231 breast cancer cells by targeted regulation of Rab1A by miR-150-5p[J]. Chinese Journal of Biochemistry and Molecular Biology(中国生物化学与分子生物学报), 2018, 34(9): 97-103. [13] ZHAO XY, LI YP, ZHANG YY, et al.miR-1297 promotes malignant biological behaviors of breast cancer MCF-7 cells by down-regulating TET3[J]. Chinese Journal of Cancer Biotherapy(中国肿瘤生物治疗杂志), 2019, 16(35): 19-21. [14] QIN AW, YU MY, GAI CC, et al.Exosome secreted by MDA-MB-231 cells deliver miR-221, miR-222 to enhance the invasion and migration of breast cancer cells under hypoxia conditions[J]. Chinese Journal of Clinical and Experimental Pathology(临床与实验病理学杂志), 2020, 36(3): 23-27. [15] WANG J, ORTIZ CW, FONTENOT L, et al.866 orally active elafin-eudragit inhibits colitis-associated intestinal fibrosis with increased Mir29C-3P and Mir205-5P expression[J]. Gastroenterology, 2019, 156(6): 193-194. [16] MA C, SHI X, GUO W, et al.Mir-205-5p downregulation decreases gemcitabine sensitivity of breast cancer cells via erp29 upregulation[J]. Exp Ther Med, 2019, 18(5): 3525-3533. |